Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies.
暂无分享,去创建一个
Chris A. Nasrallah | J. Herman | J. Licht | A. Yang | E. Sugar | S. Choi | S. Gore | H. Carraway | A. Murgo | Weijia Zhang | I. Espinoza‐Delgado | L. Silverman | Marianne K. H. Kim | T. Fandy | A. Jiemjit | Yezou Sun | M. McConnell | R. Odchimar-Reissig | Timothy Aucott | T. Dauses | P. Kerns | K. Oteiza | I. Owoeye | Weijia Zhang